Results 191 to 200 of about 11,480 (212)

Work in progress: OCT-guided coronary interventions in the acute setting. [PDF]

EuroIntervention
Prati F, Gatto L.
europepmc   +1 more source

Predictive factors for long-term survival after a platelet glycoprotein IIb/IIIa receptor blocker(Abciximab; ReoPro$^{\circledR}$) in patients undergoing high-risk percutaneous coronary intervention in acute myocardial infarction

, 2003
Weon Kim, Eun-A Chung, Myung Ho Jeong, Jihyun Lim, Han-Gyun Kim, Hyung Wook Park, Young-Joon Hong, Ok-Young Park, Ju Han Kim, Youngkeun Ahn, Jeong-Gwan Cho, Jong-Chun Park, Jung-Chaee Kang   +12 more
openalex   +1 more source

Benefit of prehospital administration of abciximab in mobile intensive care units of SAMU 54 in patients with acute myocardial infarctio treated by primary angioplasty

, 2004
Aurélien Care
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial

Lancet, The, 2008
Carlo D Di Mario, Konstantinos Dimopoulos, Achille Gaspardone   +2 more
exaly  

Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial

Lancet, The, 2012
Holger Thiele, Jochen Wöhrle, Ingo Eitel   +2 more
exaly  

Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading

Circulation, 2009
Julinda Mehilli, Adnan Kastrati, Stefanie Schulz   +2 more
exaly  

Targeting integrin pathways: mechanisms and advances in therapy

Signal Transduction and Targeted Therapy, 2023
exaly  

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial

Stroke, 2008
Mark B Effron, Werner Hacke
exaly